skip to Main Content

Welcome

Celebrating Over 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

United Healthcare Home Immunotherapy Policy Change

United Healthcare has recently announced a policy change. Effective January 1, 2023, UHC will no longer…

Read more

Medicare 2022 Conversion Factor Update

Thanks to lobbying efforts from the House of Medicine, Congress took action this month. The…

Read more

CY 2022 Physician Fee Schedule Proposed Rule Summary

On July 13, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…

Read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

06/01/23: Research Grant Cycle
Learn more

06/26/23: Membership Application Deadline to be eligible for AAOA Member rate for the 2023 Basic Course

07/01/23: Scientific Abstract Submission Deadline
Learn more

12/01/23: Research Grant Cycle
Learn more

04/01/24: Fellow Exam Application Deadline
Learn more

EDUCATION

2023 AAOA Annual Meeting

Register Now to access over 19 hrs of CME | Continuing Certification through our 2023 Hybrid Annual Meeting. The meeting will take place in Nashville and virtually from September 29 - October 1, 2023. On-Demand post course access will be open until November 14, 2023. Learn More

RESIDENTS

For information about Resident opportunities, DosedDaily, research grants, and other resources. Learn More

IFAR

Available Now

aaoaf-ifar

IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2023 AAOA Basic Course in Allergy & Immunology - Hybrid
September 1 - Access
Learn More and Register

2023 AAOA Annual Meeting - Hybrid
September 29 – October 1, 2023
Embassy Suites by Hilton Nashville Downtown
Learn More and Register

2024 AAOA Advanced Course in Allergy & Immunology - Hybrid
February 8 - 10, 2024
Hyatt Regency Tamaya
Santa Ana Pueblo, New Mexico
(outside Albuquerque)

2024 AAOA Basic Course in Allergy & Immunology - Hybrid
July 25-27, 2024
The Diplomat, Hollywood, Florida
Learn More and Get Hotel Room

2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas

USP 797 Online Module
Learn More and Register

AAOA Educational Stacks
Next Availability - November 1, 2023

News and Updates

National Study to Document Changes in Physician Practice Expense

The American Medical Association (AMA) is undertaking a new national study, supported by 173 healthcare organizations,…

Read more

American Elm Shortage

American Elm is dying from Dutch Elm Disease. This may explain the concentrate shortage many practices…

Read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

Interim Package and Resuming Non-COVID Care

Sharing the latest on the interim package and the news from CMS about resuming non-COVID care.

HILL UPDATES

  • Interim Package:
    • Despite signs of progress, an agreement on this package was not reached today. The Senate scheduled a pro forma session for Tuesday afternoon to try to pass the interim package assuming a deal is reached and the House could vote as soon as Wednesday.
    • We can expect to see approximately $300 billion for the Paycheck Protection Program (with a portion of these funds set aside for small lenders), $75 billion for providers, $65 billion for the SBA Economic Injury Disaster Loan program and $25 billion for testing.
  • COVID-4: The reports of its timing keep changing, but the latest we’ve heard from Hill staff is mid-May for the package.
  • House Energy and Commerce Chairman Pallone sent a letter to the Task Force on National Testing Strategy asking inquiring what actions the Administration taking to expand testing and prepare for eventually easing its guidelines on social distancing. Chairman Pallone requested answers to these questions by April 24, 2020.
  • Senator Patty Murray released a White Paper outlining the Democrats’ proposal to increase national COVID-19 testing.

ADMINISTRATION UPDATES

  • CMS released guidelines for some health care facilities to resume non-emergent non-COVID care in areas where there is a low incidence of COVID-19.
  • CMS has updated their FAQ on Medicare Fee-for-Service (FFS) billing here.
  • CMS Administrator Seema Verma announced that CMS expects to release data on COVID-19 outcomes specific to race and ethnicity in early May once the agency has claims from April with COVID-19 codes.
  • In an effort to ramp up testing, President Trump is invoking the Defense Production Act to produce 20 million more COVID-19 testing swabs.
  • Despite announcing that COVID-19 treatment will be covered for the uninsured, the administration still has not announced a plan to operationalize this.  POLITICO reported that a portion of the Public Health Emergency Fund could be used for this purpose.

Back To Top